@McGrupp Speaking of no volume, there's not enough volume on the ASX for the insiders to buy (assuming the restricted period is now over) without moving the share price up. Would be bad form of them not to be buying just for that reason. I expect to see buys from them eventually, even if they are as cheap, sorry, frugal, as @theonetowatch . There are several of us who will be going down with the ship, then. I really DGAS about HER2+ breast cancer, even if it's a great thing for Pax. Brain mets, WBRT and Pax is where the recurring revenue will be. Hopefully, PRV for DIPG or AT/RT in children will have happened prior to the approval for Pax in brain mets with WBRT. Serious leverage to the upside here, in my opinion.
More BS from elsewhere.
KZA Price at posting:
24.0¢ Sentiment: Buy Disclosure: Held
